Gram-Positive Infections Associated with Toxin Production
Toxin-producing Gram-positive infections are among the most acute skin and systemic conditions in dermatology. Tissue damage comes not only from direct bacterial invasion but largely from secreted protein toxins (exotoxins). The leading culprits are Staphylococcus aureus and group A streptococcus (Streptococcus pyogenes). Their toxins fall into three main pathogenic groups: superantigens, which cause toxic shock syndrome (TSS); exfoliative toxins, which cause staphylococcal scalded skin syndrome (SSSS); and tissue-destroying, pore-forming toxins (cytotoxins such as PVL and alpha-hemolysin), which cause necrotizing fasciitis and deep necrotic skin lesions. A surge of toxin in the circulation triggers a systemic inflammatory response (SIRS), vascular collapse and widespread shedding of the epidermis. At Haute-Derma, we focus on recognizing red-flag signs early, removing the toxin source, supporting the circulation, and using antibiotic combinations that urgently block toxin protein synthesis.
How these toxins damage the skin and immune system:
- Superantigens and the Cytokine Storm of Toxic Shock Syndrome (TSS):
- TSST-1 (S. aureus) or streptococcal pyrogenic exotoxins (SPEA/C) bind directly to MHC class II molecules on antigen-presenting cells and to the V-beta region of the T-cell receptor (TCR), bypassing normal antigen processing.
- This activates up to 20% of all the body's T cells at once (compared with 0.001% in a normal response), unleashing a cytokine storm (TNF-alpha, IL-1, IL-2, IFN-gamma) that leads to widespread vasodilation, plasma leakage, low blood pressure and multiple organ failure.
- Exfoliative Toxins ETA/ETB and Cleavage of Desmoglein 1 in SSSS:
- Exfoliative toxins A and B (ETA/ETB) secreted by S. aureus are extracellular serine proteases. Carried throughout the body in the bloodstream, they specifically cleave the extracellular portion of desmoglein 1 (DSG1) in the granular layer of the epidermis.
- Because DSG1 is expressed only in the upper epidermis, this cleavage separates keratinocytes (acantholysis) just beneath the stratum corneum, so the entire superficial epidermis peels away in sheets as if scalded by boiling water, while the dermis is spared.
- The Pore-Forming Toxin PVL (Panton-Valentine Leukocidin) and Destruction of Fat Cells and White Cells:
- PVL, secreted by certain S. aureus strains (especially CA-MRSA), binds to the C5a receptor on neutrophils and macrophages and punches pores in their cell membranes.
- As the white cells burst, they release large amounts of proteases and intracellular cytokines that cause extensive tissue necrosis, forming deep necrotic boils and rapidly destructive skin lesions.
Clinical Features by Toxin Type
| Condition | Main bacterial toxin | Characteristic skin findings |
|---|---|---|
| Staphylococcal scalded skin syndrome (SSSS) | Exfoliative toxins A and B (ETA/ETB) (S. aureus) | Redness around the body openings; thin, fragile blisters; positive Nikolsky sign; widespread burn-like peeling. |
| Staphylococcal toxic shock syndrome (TSS) | TSST-1, enterotoxin B (S. aureus) | Generalized red rash (diffuse erythroderma), followed by fine peeling of the palms and soles after 1–2 weeks. |
| Streptococcal toxic shock syndrome (STSS) | Streptococcal pyrogenic exotoxins (SPEA/B/C) | Often begins as necrotizing cellulitis, with severe pain out of proportion to the visible damage and rapidly spreading redness. |
| PVL-associated necrotizing infection | Panton-Valentine leukocidin (PVL) (CA-MRSA) | Recurrent boils; abscesses with a black-purple necrotic center and a wide necrotic rim; very painful. |
SSSS vs. Toxic Epidermal Necrolysis (TEN) vs. Staphylococcal TSS
| SSSS (staphylococcal scalded skin syndrome) | TEN (toxic epidermal necrolysis) | Staphylococcal TSS |
|---|---|---|
| Blood-borne exfoliative toxin | Delayed, necrotizing drug hypersensitivity reaction | Superantigen-driven cytokine storm |
| Superficial epidermis (granular/spinous layer) | Full thickness of the epidermis (down to the basal layer) | No epidermal separation in the acute phase |
| Minimal or NO mucosal involvement | Very severe mucosal involvement (eyes, mouth, genitals) | Mucosal redness (eyes, strawberry tongue) |
| Only the upper layer peels off; no necrotic cells | Necrosis of all epidermal keratinocytes | No epidermal separation |
| Low mortality in children (< 5%) | Very high mortality (30–50%) | Moderate to high mortality (5–15%) |
Our Approach
At Haute-Derma, suspected toxin-producing Gram-positive infections call for a rigorous microbiological workup and careful risk stratification:
- Frozen section biopsy: A frozen section of the peeling skin immediately distinguishes SSSS (separation only in the superficial granular layer) from TEN (necrosis of the full epidermis down to the basal layer).
- Microbiological Isolation and Search for the Primary Infection Site:
- Samples are taken from the primary site of infection (ear, nose, throat, superficial wounds, or the tampon site in TSS) for Gram stain and culture for S. aureus or S. pyogenes.
- Important: in SSSS, the skin blisters are sterile, because the damage is caused by circulating toxin and the bacteria are not in the blisters.
- Hemodynamic and End-Organ Assessment: Central venous pressure, arterial blood pressure, arterial blood gases, blood lactate and liver/kidney function are closely monitored to detect septic shock and cytokine storm early.
Treatment at Haute-Derma
Our treatment plan combines removing the bacterial source, neutralizing toxins, countering the cytokine storm, and pairing a bactericidal antibiotic with one that shuts down toxin production:
- Antibiotic Combinations That BLOCK TOXIN PRODUCTION (Protein Synthesis Inhibition):
- Core principle: combine a cell wall–active antibiotic (such as vancomycin, cefazolin or oxacillin) with clindamycin or linezolid.
- Clindamycin or linezolid is added to shut down the bacterial ribosome and immediately stop the production of new toxin (TSST-1, ETA/ETB, PVL), even before the bacteria have been fully killed.
- Toxin Neutralization and Immune Balance at Haute-Derma:
- Intravenous immunoglobulin (IVIG): supplies antibodies that neutralize superantigens and exfoliative toxins in severe TSS or rapidly progressing SSSS.
- High-volume fluid resuscitation, guided by intravascular pressure monitoring, replaces fluid lost through capillary leak and skin peeling.
- Skin Care and Control of the Primary Infection Site:
- Treat the source: remove any vaginal tampon immediately, drain abscesses and debride necrotic tissue.
- Care for the skin as for a minor burn: non-adherent petrolatum gauze plus hypochlorous acid (HOCl) spray to keep the skin moist and prevent secondary infection. Never rub the skin, as this can strip off more epidermis.
